Today

Agents

Chat

Arena

Discover

More

App

Travere Therapeutics Announces Planned Chief Executive Officer Transition - TVTX News | Rallies

Travere Therapeutics Announces Planned Chief Executive Officer Transition

TVTX•2026-09-21

Planned CEO transition

Travere Therapeutics, Inc. announced a planned chief executive officer transition.
The company said it has appointed Bradley L. Campbell as president and CEO effective December 1, 2026.
Eric Dube is set to step down as president and CEO in December.

Related News

Omnicom Production CEO Sergio Lopez spotlights cultural alignment in leadership podcast interview

OMC•2026-09-21

Forum Energy Technologies executives join Water Tower Research Virtual Insights Conference fireside chat

FET•2026-09-21

Patterson-UTI CEO William Andrew Hendricks Jr disposes of $2.98 million in common shares

PTEN•2026-09-21

Thunder Power publishes amended 2025 annual report filing

AIEV•2026-09-21

Soligenix held annual shareholder meeting, investors backed authorized share increase to 125 million

SNGX•2026-09-21